Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-month analysis of the E-ZO-FAST trial (Q45496960)

From Wikidata
Jump to navigation Jump to search
scientific article published on 19 October 2011
edit
Language Label Description Also known as
English
Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-month analysis of the E-ZO-FAST trial
scientific article published on 19 October 2011

    Statements

    Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-month analysis of the E-ZO-FAST trial (English)
    Antonio Llombart
    Antonio Frassoldati
    Outi Paija
    Harm Peter Sleeboom
    Guy Jerusalem
    Jeroen Mebis
    Ines Deleu
    Joel Miller
    Nora Schenk
    19 October 2011
    40-48

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit